nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A5—prostate cancer	0.132	0.473	CbGaD
Quetiapine—CYP2C19—prostate cancer	0.0898	0.322	CbGaD
Quetiapine—CYP3A4—prostate cancer	0.0571	0.205	CbGaD
Quetiapine—CYP3A5—Flutamide—prostate cancer	0.0196	0.0556	CbGbCtD
Quetiapine—CYP2C19—Bicalutamide—prostate cancer	0.0191	0.0541	CbGbCtD
Quetiapine—CYP2C19—Nilutamide—prostate cancer	0.0191	0.0541	CbGbCtD
Quetiapine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0176	0.0498	CbGbCtD
Quetiapine—CYP2C19—Flutamide—prostate cancer	0.0158	0.0448	CbGbCtD
Quetiapine—CYP2D6—Bicalutamide—prostate cancer	0.0145	0.0411	CbGbCtD
Quetiapine—CYP3A5—Cabazitaxel—prostate cancer	0.0145	0.0411	CbGbCtD
Quetiapine—ABCB1—Estramustine—prostate cancer	0.0143	0.0406	CbGbCtD
Quetiapine—CYP3A5—Estrone—prostate cancer	0.0142	0.0402	CbGbCtD
Quetiapine—CYP2D6—Abiraterone—prostate cancer	0.012	0.0341	CbGbCtD
Quetiapine—ADRA1B—vas deferens—prostate cancer	0.0112	0.203	CbGeAlD
Quetiapine—CYP3A7—Estradiol—prostate cancer	0.0108	0.0308	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0108	0.0308	CbGbCtD
Quetiapine—ABCB1—Cabazitaxel—prostate cancer	0.00944	0.0268	CbGbCtD
Quetiapine—CYP3A4—Bicalutamide—prostate cancer	0.00922	0.0262	CbGbCtD
Quetiapine—ABCB1—Estrone—prostate cancer	0.00922	0.0262	CbGbCtD
Quetiapine—CYP3A4—Estramustine—prostate cancer	0.00857	0.0243	CbGbCtD
Quetiapine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00822	0.0233	CbGbCtD
Quetiapine—CYP3A5—Estradiol—prostate cancer	0.00814	0.0231	CbGbCtD
Quetiapine—CYP3A4—Abiraterone—prostate cancer	0.00764	0.0217	CbGbCtD
Quetiapine—CYP3A4—Flutamide—prostate cancer	0.00764	0.0217	CbGbCtD
Quetiapine—CYP2C19—Estradiol—prostate cancer	0.00656	0.0186	CbGbCtD
Quetiapine—HTR7—vas deferens—prostate cancer	0.00652	0.118	CbGeAlD
Quetiapine—CYP3A7—Docetaxel—prostate cancer	0.00648	0.0184	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00648	0.0184	CbGbCtD
Quetiapine—ABCB1—Conjugated Estrogens—prostate cancer	0.00603	0.0171	CbGbCtD
Quetiapine—CYP3A4—Cabazitaxel—prostate cancer	0.00565	0.016	CbGbCtD
Quetiapine—CYP2C19—Prednisone—prostate cancer	0.00565	0.016	CbGbCtD
Quetiapine—CYP3A4—Estrone—prostate cancer	0.00553	0.0157	CbGbCtD
Quetiapine—ABCB1—Mitoxantrone—prostate cancer	0.00548	0.0156	CbGbCtD
Quetiapine—CYP3A5—Etoposide—prostate cancer	0.00531	0.0151	CbGbCtD
Quetiapine—ABCB1—Estradiol—prostate cancer	0.0053	0.015	CbGbCtD
Quetiapine—CHRM3—ureter—prostate cancer	0.00524	0.0952	CbGeAlD
Quetiapine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00493	0.014	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—prostate cancer	0.00486	0.0138	CbGbCtD
Quetiapine—ABCB1—Prednisone—prostate cancer	0.00455	0.0129	CbGbCtD
Quetiapine—H1F0—semen—prostate cancer	0.00376	0.0684	CbGeAlD
Quetiapine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00361	0.0103	CbGbCtD
Quetiapine—ABCB1—Etoposide—prostate cancer	0.00346	0.00981	CbGbCtD
Quetiapine—CYP3A4—Mitoxantrone—prostate cancer	0.00329	0.00932	CbGbCtD
Quetiapine—CYP3A4—Estradiol—prostate cancer	0.00317	0.009	CbGbCtD
Quetiapine—ABCB1—Docetaxel—prostate cancer	0.00316	0.00897	CbGbCtD
Quetiapine—CYP3A4—Prednisone—prostate cancer	0.00273	0.00774	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—prostate cancer	0.00236	0.00669	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—prostate cancer	0.00222	0.0063	CbGbCtD
Quetiapine—CYP3A4—Etoposide—prostate cancer	0.00207	0.00588	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—prostate cancer	0.0019	0.00538	CbGbCtD
Quetiapine—CYP2C19—urine—prostate cancer	0.00158	0.0288	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—prostate cancer	0.00141	0.00401	CbGbCtD
Quetiapine—HTR2A—urine—prostate cancer	0.00101	0.0184	CbGeAlD
Quetiapine—ADRA1D—prostate gland—prostate cancer	0.000978	0.0178	CbGeAlD
Quetiapine—H1F0—prostate gland—prostate cancer	0.000944	0.0171	CbGeAlD
Quetiapine—CYP3A4—urine—prostate cancer	0.000936	0.017	CbGeAlD
Quetiapine—CYP2D6—urine—prostate cancer	0.000921	0.0167	CbGeAlD
Quetiapine—DRD4—testis—prostate cancer	0.000816	0.0148	CbGeAlD
Quetiapine—CHRM5—epithelium—prostate cancer	0.000804	0.0146	CbGeAlD
Quetiapine—H1F0—seminal vesicle—prostate cancer	0.000798	0.0145	CbGeAlD
Quetiapine—CHRM2—prostate gland—prostate cancer	0.000751	0.0136	CbGeAlD
Quetiapine—ADRA1D—epithelium—prostate cancer	0.000719	0.013	CbGeAlD
Quetiapine—CHRM1—prostate gland—prostate cancer	0.000684	0.0124	CbGeAlD
Quetiapine—ADRA1B—renal system—prostate cancer	0.000681	0.0124	CbGeAlD
Quetiapine—ADRA1D—urethra—prostate cancer	0.000655	0.0119	CbGeAlD
Quetiapine—H1F0—renal system—prostate cancer	0.000643	0.0117	CbGeAlD
Quetiapine—H1F0—urethra—prostate cancer	0.000632	0.0115	CbGeAlD
Quetiapine—CHRM4—testis—prostate cancer	0.000617	0.0112	CbGeAlD
Quetiapine—CHRM3—prostate gland—prostate cancer	0.000612	0.0111	CbGeAlD
Quetiapine—ADRA1A—prostate gland—prostate cancer	0.000562	0.0102	CbGeAlD
Quetiapine—ADRA2C—prostate gland—prostate cancer	0.000535	0.00972	CbGeAlD
Quetiapine—H1F0—bone marrow—prostate cancer	0.000486	0.00883	CbGeAlD
Quetiapine—ADRA2C—seminal vesicle—prostate cancer	0.000453	0.00822	CbGeAlD
Quetiapine—CYP3A5—prostate gland—prostate cancer	0.000448	0.00813	CbGeAlD
Quetiapine—HRH1—prostate gland—prostate cancer	0.000435	0.0079	CbGeAlD
Quetiapine—HTR7—epithelium—prostate cancer	0.000428	0.00777	CbGeAlD
Quetiapine—ADRA2A—prostate gland—prostate cancer	0.000427	0.00775	CbGeAlD
Quetiapine—CHRM3—renal system—prostate cancer	0.000417	0.00757	CbGeAlD
Quetiapine—H1F0—testis—prostate cancer	0.000416	0.00755	CbGeAlD
Quetiapine—HTR1A—renal system—prostate cancer	0.000415	0.00754	CbGeAlD
Quetiapine—ADRA1A—epithelium—prostate cancer	0.000413	0.00749	CbGeAlD
Quetiapine—CHRM3—urethra—prostate cancer	0.00041	0.00744	CbGeAlD
Quetiapine—HTR7—renal system—prostate cancer	0.000397	0.00721	CbGeAlD
Quetiapine—ADRA1A—renal system—prostate cancer	0.000383	0.00695	CbGeAlD
Quetiapine—ADRA2C—renal system—prostate cancer	0.000365	0.00662	CbGeAlD
Quetiapine—ADRA2A—seminal vesicle—prostate cancer	0.000361	0.00656	CbGeAlD
Quetiapine—ADRA2C—urethra—prostate cancer	0.000358	0.00651	CbGeAlD
Quetiapine—HRH1—epithelium—prostate cancer	0.000319	0.0058	CbGeAlD
Quetiapine—CYP3A5—renal system—prostate cancer	0.000305	0.00554	CbGeAlD
Quetiapine—H1F0—lymph node—prostate cancer	0.000301	0.00547	CbGeAlD
Quetiapine—Perphenazine—AOX1—prostate cancer	0.000294	0.126	CrCbGaD
Quetiapine—HRH1—urethra—prostate cancer	0.000291	0.00529	CbGeAlD
Quetiapine—ADRA2A—urethra—prostate cancer	0.000286	0.00519	CbGeAlD
Quetiapine—CHRM3—testis—prostate cancer	0.000269	0.00489	CbGeAlD
Quetiapine—HTR2A—epithelium—prostate cancer	0.000267	0.00485	CbGeAlD
Quetiapine—HTR7—testis—prostate cancer	0.000257	0.00466	CbGeAlD
Quetiapine—HTR2A—renal system—prostate cancer	0.000247	0.00449	CbGeAlD
Quetiapine—DRD2—testis—prostate cancer	0.000243	0.0044	CbGeAlD
Quetiapine—ABCB1—prostate gland—prostate cancer	0.000238	0.00432	CbGeAlD
Quetiapine—ADRA2C—testis—prostate cancer	0.000236	0.00428	CbGeAlD
Quetiapine—CYP3A4—renal system—prostate cancer	0.000229	0.00416	CbGeAlD
Quetiapine—CYP2D6—renal system—prostate cancer	0.000225	0.00409	CbGeAlD
Quetiapine—ABCB1—seminal vesicle—prostate cancer	0.000201	0.00365	CbGeAlD
Quetiapine—HRH1—testis—prostate cancer	0.000192	0.00348	CbGeAlD
Quetiapine—ADRA2A—testis—prostate cancer	0.000188	0.00342	CbGeAlD
Quetiapine—ABCB1—epithelium—prostate cancer	0.000175	0.00318	CbGeAlD
Quetiapine—ADRA2C—lymph node—prostate cancer	0.000171	0.0031	CbGeAlD
Quetiapine—ABCB1—renal system—prostate cancer	0.000162	0.00295	CbGeAlD
Quetiapine—HTR2A—testis—prostate cancer	0.00016	0.0029	CbGeAlD
Quetiapine—Thioproperazine—SLC22A1—prostate cancer	0.00016	0.0685	CrCbGaD
Quetiapine—ABCB1—urethra—prostate cancer	0.000159	0.00289	CbGeAlD
Quetiapine—Thiothixene—SLC22A1—prostate cancer	0.000157	0.0674	CrCbGaD
Quetiapine—Pipotiazine—SLC22A1—prostate cancer	0.000157	0.0674	CrCbGaD
Quetiapine—Nefazodone—CYP3A5—prostate cancer	0.000146	0.0627	CrCbGaD
Quetiapine—CYP2D6—testis—prostate cancer	0.000146	0.00265	CbGeAlD
Quetiapine—HRH1—lymph node—prostate cancer	0.000139	0.00252	CbGeAlD
Quetiapine—ADRA2A—lymph node—prostate cancer	0.000136	0.00248	CbGeAlD
Quetiapine—Trazodone—CYP3A5—prostate cancer	0.000135	0.058	CrCbGaD
Quetiapine—Perphenazine—CYP2C18—prostate cancer	0.000132	0.0564	CrCbGaD
Quetiapine—ABCB1—bone marrow—prostate cancer	0.000123	0.00223	CbGeAlD
Quetiapine—ABCB1—testis—prostate cancer	0.000105	0.0019	CbGeAlD
Quetiapine—Olanzapine—CYP2C19—prostate cancer	9.54e-05	0.0409	CrCbGaD
Quetiapine—Clozapine—CYP1B1—prostate cancer	9.19e-05	0.0394	CrCbGaD
Quetiapine—Pipotiazine—CYP2C19—prostate cancer	8.64e-05	0.037	CrCbGaD
Quetiapine—Mequitazine—CYP3A4—prostate cancer	7.72e-05	0.0331	CrCbGaD
Quetiapine—ABCB1—lymph node—prostate cancer	7.6e-05	0.00138	CbGeAlD
Quetiapine—Fluphenazine—CYP2E1—prostate cancer	7.54e-05	0.0323	CrCbGaD
Quetiapine—Clozapine—CYP2A6—prostate cancer	7.08e-05	0.0303	CrCbGaD
Quetiapine—Nefazodone—CYP3A4—prostate cancer	6.34e-05	0.0271	CrCbGaD
Quetiapine—Olanzapine—CYP3A4—prostate cancer	6.07e-05	0.026	CrCbGaD
Quetiapine—Perphenazine—CYP2C19—prostate cancer	5.9e-05	0.0253	CrCbGaD
Quetiapine—Trazodone—CYP3A4—prostate cancer	5.86e-05	0.0251	CrCbGaD
Quetiapine—Pipotiazine—CYP3A4—prostate cancer	5.49e-05	0.0235	CrCbGaD
Quetiapine—Promazine—CYP2C19—prostate cancer	5.32e-05	0.0228	CrCbGaD
Quetiapine—Prochlorperazine—CYP3A4—prostate cancer	5.25e-05	0.0225	CrCbGaD
Quetiapine—Clozapine—CYP2E1—prostate cancer	5.03e-05	0.0215	CrCbGaD
Quetiapine—Clozapine—CYP2C19—prostate cancer	4.98e-05	0.0213	CrCbGaD
Quetiapine—Clozapine—CYP1A1—prostate cancer	4.96e-05	0.0213	CrCbGaD
Quetiapine—Perphenazine—CYP3A4—prostate cancer	3.75e-05	0.0161	CrCbGaD
Quetiapine—Promazine—CYP3A4—prostate cancer	3.38e-05	0.0145	CrCbGaD
Quetiapine—Clozapine—CYP3A4—prostate cancer	3.17e-05	0.0136	CrCbGaD
Quetiapine—Hypotension—Capecitabine—prostate cancer	2.25e-05	0.000111	CcSEcCtD
Quetiapine—Insomnia—Docetaxel—prostate cancer	2.25e-05	0.000111	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—prostate cancer	2.24e-05	0.00011	CcSEcCtD
Quetiapine—Myalgia—Prednisone—prostate cancer	2.24e-05	0.00011	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—prostate cancer	2.23e-05	0.00011	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—prostate cancer	2.23e-05	0.00011	CcSEcCtD
Quetiapine—Anxiety—Prednisone—prostate cancer	2.23e-05	0.00011	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—prostate cancer	2.22e-05	0.00011	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.22e-05	0.000109	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—prostate cancer	2.22e-05	0.000109	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—prostate cancer	2.21e-05	0.000109	CcSEcCtD
Quetiapine—Discomfort—Prednisone—prostate cancer	2.21e-05	0.000109	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—prostate cancer	2.2e-05	0.000109	CcSEcCtD
Quetiapine—Hypersensitivity—Etoposide—prostate cancer	2.2e-05	0.000109	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—prostate cancer	2.2e-05	0.000108	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—prostate cancer	2.19e-05	0.000108	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.19e-05	0.000108	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—prostate cancer	2.19e-05	0.000108	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—prostate cancer	2.19e-05	0.000108	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—prostate cancer	2.19e-05	0.000108	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—prostate cancer	2.18e-05	0.000108	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—prostate cancer	2.18e-05	0.000108	CcSEcCtD
Quetiapine—Insomnia—Capecitabine—prostate cancer	2.18e-05	0.000107	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—prostate cancer	2.17e-05	0.000107	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—prostate cancer	2.17e-05	0.000107	CcSEcCtD
Quetiapine—Paraesthesia—Capecitabine—prostate cancer	2.16e-05	0.000107	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—prostate cancer	2.16e-05	0.000107	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—prostate cancer	2.16e-05	0.000106	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—prostate cancer	2.15e-05	0.000106	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.15e-05	0.000106	CcSEcCtD
Quetiapine—Asthenia—Etoposide—prostate cancer	2.15e-05	0.000106	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Dyspnoea—Capecitabine—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisone—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—prostate cancer	2.14e-05	0.000106	CcSEcCtD
Quetiapine—Nausea—Mitoxantrone—prostate cancer	2.14e-05	0.000105	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—prostate cancer	2.13e-05	0.000105	CcSEcCtD
Quetiapine—Infection—Prednisone—prostate cancer	2.13e-05	0.000105	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—prostate cancer	2.13e-05	0.000105	CcSEcCtD
Quetiapine—Pain—Docetaxel—prostate cancer	2.12e-05	0.000105	CcSEcCtD
Quetiapine—Constipation—Docetaxel—prostate cancer	2.12e-05	0.000105	CcSEcCtD
Quetiapine—Dyspepsia—Capecitabine—prostate cancer	2.12e-05	0.000104	CcSEcCtD
Quetiapine—Chills—Epirubicin—prostate cancer	2.12e-05	0.000104	CcSEcCtD
Quetiapine—Pruritus—Etoposide—prostate cancer	2.12e-05	0.000104	CcSEcCtD
Quetiapine—Shock—Prednisone—prostate cancer	2.11e-05	0.000104	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—prostate cancer	2.1e-05	0.000104	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—prostate cancer	2.1e-05	0.000104	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—prostate cancer	2.09e-05	0.000103	CcSEcCtD
Quetiapine—Decreased appetite—Capecitabine—prostate cancer	2.09e-05	0.000103	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—prostate cancer	2.08e-05	0.000103	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.08e-05	0.000102	CcSEcCtD
Quetiapine—Fatigue—Capecitabine—prostate cancer	2.07e-05	0.000102	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—prostate cancer	2.07e-05	0.000102	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—prostate cancer	2.07e-05	0.000102	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—prostate cancer	2.06e-05	0.000102	CcSEcCtD
Quetiapine—Pain—Capecitabine—prostate cancer	2.06e-05	0.000101	CcSEcCtD
Quetiapine—Constipation—Capecitabine—prostate cancer	2.06e-05	0.000101	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—prostate cancer	2.05e-05	0.000101	CcSEcCtD
Quetiapine—Anorexia—Prednisone—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—prostate cancer	2.04e-05	0.000101	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—prostate cancer	2.04e-05	0.0001	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—prostate cancer	2.03e-05	0.0001	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—prostate cancer	2.03e-05	9.99e-05	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—prostate cancer	2.02e-05	9.98e-05	CcSEcCtD
Quetiapine—Tension—Epirubicin—prostate cancer	2.02e-05	9.94e-05	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—prostate cancer	2.01e-05	9.92e-05	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—prostate cancer	1.99e-05	9.84e-05	CcSEcCtD
Quetiapine—Back pain—Epirubicin—prostate cancer	1.99e-05	9.8e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Capecitabine—prostate cancer	1.98e-05	9.78e-05	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—prostate cancer	1.98e-05	9.77e-05	CcSEcCtD
Quetiapine—Dizziness—Etoposide—prostate cancer	1.98e-05	9.75e-05	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—prostate cancer	1.97e-05	9.74e-05	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—prostate cancer	1.97e-05	9.72e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Capecitabine—prostate cancer	1.97e-05	9.7e-05	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—prostate cancer	1.97e-05	9.7e-05	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—prostate cancer	1.96e-05	9.69e-05	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—prostate cancer	1.96e-05	9.69e-05	CcSEcCtD
Quetiapine—Chills—Doxorubicin—prostate cancer	1.96e-05	9.66e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.95e-05	9.63e-05	CcSEcCtD
Quetiapine—Insomnia—Prednisone—prostate cancer	1.94e-05	9.56e-05	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—prostate cancer	1.94e-05	9.55e-05	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—prostate cancer	1.92e-05	9.49e-05	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—prostate cancer	1.91e-05	9.43e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—prostate cancer	1.91e-05	9.4e-05	CcSEcCtD
Quetiapine—Body temperature increased—Capecitabine—prostate cancer	1.9e-05	9.38e-05	CcSEcCtD
Quetiapine—Abdominal pain—Capecitabine—prostate cancer	1.9e-05	9.38e-05	CcSEcCtD
Quetiapine—Vomiting—Etoposide—prostate cancer	1.9e-05	9.38e-05	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—prostate cancer	1.9e-05	9.37e-05	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—prostate cancer	1.9e-05	9.36e-05	CcSEcCtD
Quetiapine—Agitation—Epirubicin—prostate cancer	1.89e-05	9.31e-05	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—prostate cancer	1.89e-05	9.3e-05	CcSEcCtD
Quetiapine—Rash—Etoposide—prostate cancer	1.89e-05	9.3e-05	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—prostate cancer	1.88e-05	9.29e-05	CcSEcCtD
Quetiapine—Headache—Etoposide—prostate cancer	1.87e-05	9.24e-05	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—prostate cancer	1.87e-05	9.23e-05	CcSEcCtD
Quetiapine—Tension—Doxorubicin—prostate cancer	1.86e-05	9.2e-05	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—prostate cancer	1.86e-05	9.19e-05	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—prostate cancer	1.86e-05	9.18e-05	CcSEcCtD
Quetiapine—Malaise—Epirubicin—prostate cancer	1.85e-05	9.13e-05	CcSEcCtD
Quetiapine—Fatigue—Prednisone—prostate cancer	1.85e-05	9.11e-05	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—prostate cancer	1.85e-05	9.1e-05	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—prostate cancer	1.84e-05	9.1e-05	CcSEcCtD
Quetiapine—Syncope—Epirubicin—prostate cancer	1.84e-05	9.08e-05	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—prostate cancer	1.84e-05	9.07e-05	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—prostate cancer	1.84e-05	9.06e-05	CcSEcCtD
Quetiapine—Constipation—Prednisone—prostate cancer	1.83e-05	9.04e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—prostate cancer	1.83e-05	9.03e-05	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—prostate cancer	1.83e-05	9.01e-05	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—prostate cancer	1.81e-05	8.95e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—prostate cancer	1.8e-05	8.9e-05	CcSEcCtD
Quetiapine—Cough—Epirubicin—prostate cancer	1.79e-05	8.84e-05	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—prostate cancer	1.79e-05	8.83e-05	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—prostate cancer	1.78e-05	8.79e-05	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—prostate cancer	1.78e-05	8.78e-05	CcSEcCtD
Quetiapine—Nausea—Etoposide—prostate cancer	1.78e-05	8.76e-05	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—prostate cancer	1.77e-05	8.74e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Capecitabine—prostate cancer	1.77e-05	8.74e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—prostate cancer	1.77e-05	8.71e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—prostate cancer	1.76e-05	8.7e-05	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—prostate cancer	1.76e-05	8.67e-05	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—prostate cancer	1.76e-05	8.66e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—prostate cancer	1.75e-05	8.64e-05	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—prostate cancer	1.75e-05	8.62e-05	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—prostate cancer	1.75e-05	8.62e-05	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—prostate cancer	1.75e-05	8.62e-05	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—prostate cancer	1.75e-05	8.61e-05	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—prostate cancer	1.74e-05	8.59e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.74e-05	8.56e-05	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—prostate cancer	1.73e-05	8.52e-05	CcSEcCtD
Quetiapine—Asthenia—Capecitabine—prostate cancer	1.73e-05	8.51e-05	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—prostate cancer	1.71e-05	8.45e-05	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—prostate cancer	1.71e-05	8.43e-05	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—prostate cancer	1.71e-05	8.42e-05	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—prostate cancer	1.7e-05	8.4e-05	CcSEcCtD
Quetiapine—Pruritus—Capecitabine—prostate cancer	1.7e-05	8.39e-05	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—prostate cancer	1.7e-05	8.39e-05	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—prostate cancer	1.7e-05	8.38e-05	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—prostate cancer	1.69e-05	8.35e-05	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—prostate cancer	1.69e-05	8.35e-05	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—prostate cancer	1.69e-05	8.33e-05	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—prostate cancer	1.68e-05	8.28e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—prostate cancer	1.68e-05	8.27e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—prostate cancer	1.67e-05	8.24e-05	CcSEcCtD
Quetiapine—Infection—Epirubicin—prostate cancer	1.66e-05	8.21e-05	CcSEcCtD
Quetiapine—Cough—Doxorubicin—prostate cancer	1.66e-05	8.18e-05	CcSEcCtD
Quetiapine—Shock—Epirubicin—prostate cancer	1.65e-05	8.13e-05	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—prostate cancer	1.65e-05	8.12e-05	CcSEcCtD
Quetiapine—Diarrhoea—Capecitabine—prostate cancer	1.65e-05	8.12e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—prostate cancer	1.64e-05	8.11e-05	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—prostate cancer	1.64e-05	8.1e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—prostate cancer	1.64e-05	8.09e-05	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—prostate cancer	1.64e-05	8.09e-05	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—prostate cancer	1.64e-05	8.07e-05	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—prostate cancer	1.63e-05	8.03e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—prostate cancer	1.62e-05	7.99e-05	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—prostate cancer	1.62e-05	7.98e-05	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—prostate cancer	1.62e-05	7.98e-05	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—prostate cancer	1.62e-05	7.98e-05	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—prostate cancer	1.61e-05	7.95e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.61e-05	7.92e-05	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—prostate cancer	1.6e-05	7.88e-05	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—prostate cancer	1.6e-05	7.88e-05	CcSEcCtD
Quetiapine—Dizziness—Capecitabine—prostate cancer	1.59e-05	7.85e-05	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—prostate cancer	1.58e-05	7.8e-05	CcSEcCtD
Quetiapine—Vomiting—Docetaxel—prostate cancer	1.58e-05	7.79e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—prostate cancer	1.58e-05	7.79e-05	CcSEcCtD
Quetiapine—Rash—Docetaxel—prostate cancer	1.57e-05	7.73e-05	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—prostate cancer	1.57e-05	7.72e-05	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—prostate cancer	1.57e-05	7.72e-05	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—prostate cancer	1.56e-05	7.71e-05	CcSEcCtD
Quetiapine—Headache—Docetaxel—prostate cancer	1.56e-05	7.68e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—prostate cancer	1.55e-05	7.65e-05	CcSEcCtD
Quetiapine—Infection—Doxorubicin—prostate cancer	1.54e-05	7.6e-05	CcSEcCtD
Quetiapine—Asthenia—Prednisone—prostate cancer	1.54e-05	7.58e-05	CcSEcCtD
Quetiapine—Vomiting—Capecitabine—prostate cancer	1.53e-05	7.54e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.53e-05	7.53e-05	CcSEcCtD
Quetiapine—Shock—Doxorubicin—prostate cancer	1.53e-05	7.52e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—prostate cancer	1.52e-05	7.5e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—prostate cancer	1.52e-05	7.49e-05	CcSEcCtD
Quetiapine—Rash—Capecitabine—prostate cancer	1.52e-05	7.48e-05	CcSEcCtD
Quetiapine—Pruritus—Prednisone—prostate cancer	1.52e-05	7.48e-05	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—prostate cancer	1.52e-05	7.48e-05	CcSEcCtD
Quetiapine—Dermatitis—Capecitabine—prostate cancer	1.52e-05	7.47e-05	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—prostate cancer	1.51e-05	7.46e-05	CcSEcCtD
Quetiapine—Headache—Capecitabine—prostate cancer	1.51e-05	7.43e-05	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—prostate cancer	1.51e-05	7.43e-05	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—prostate cancer	1.5e-05	7.42e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—prostate cancer	1.5e-05	7.39e-05	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—prostate cancer	1.49e-05	7.37e-05	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—prostate cancer	1.49e-05	7.35e-05	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—prostate cancer	1.48e-05	7.29e-05	CcSEcCtD
Quetiapine—Nausea—Docetaxel—prostate cancer	1.48e-05	7.28e-05	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—prostate cancer	1.48e-05	7.28e-05	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—prostate cancer	1.47e-05	7.23e-05	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—prostate cancer	1.46e-05	7.19e-05	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—prostate cancer	1.45e-05	7.15e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.45e-05	7.14e-05	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—prostate cancer	1.44e-05	7.13e-05	CcSEcCtD
Quetiapine—Constipation—Epirubicin—prostate cancer	1.43e-05	7.07e-05	CcSEcCtD
Quetiapine—Pain—Epirubicin—prostate cancer	1.43e-05	7.07e-05	CcSEcCtD
Quetiapine—Nausea—Capecitabine—prostate cancer	1.43e-05	7.05e-05	CcSEcCtD
Quetiapine—Dizziness—Prednisone—prostate cancer	1.42e-05	6.99e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.41e-05	6.97e-05	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—prostate cancer	1.4e-05	6.92e-05	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—prostate cancer	1.39e-05	6.87e-05	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—prostate cancer	1.38e-05	6.82e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—prostate cancer	1.38e-05	6.81e-05	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—prostate cancer	1.38e-05	6.8e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—prostate cancer	1.37e-05	6.76e-05	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—prostate cancer	1.37e-05	6.73e-05	CcSEcCtD
Quetiapine—Vomiting—Prednisone—prostate cancer	1.36e-05	6.72e-05	CcSEcCtD
Quetiapine—Rash—Prednisone—prostate cancer	1.35e-05	6.66e-05	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—prostate cancer	1.35e-05	6.66e-05	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—prostate cancer	1.35e-05	6.65e-05	CcSEcCtD
Quetiapine—Headache—Prednisone—prostate cancer	1.34e-05	6.62e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.34e-05	6.6e-05	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—prostate cancer	1.34e-05	6.59e-05	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—prostate cancer	1.33e-05	6.54e-05	CcSEcCtD
Quetiapine—Pain—Doxorubicin—prostate cancer	1.33e-05	6.54e-05	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—prostate cancer	1.32e-05	6.53e-05	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—prostate cancer	1.32e-05	6.53e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—prostate cancer	1.28e-05	6.3e-05	CcSEcCtD
Quetiapine—Nausea—Prednisone—prostate cancer	1.27e-05	6.28e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.27e-05	6.25e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—prostate cancer	1.23e-05	6.09e-05	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—prostate cancer	1.23e-05	6.05e-05	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—prostate cancer	1.23e-05	6.05e-05	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—prostate cancer	1.2e-05	5.93e-05	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—prostate cancer	1.19e-05	5.85e-05	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—prostate cancer	1.15e-05	5.66e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—prostate cancer	1.14e-05	5.63e-05	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—prostate cancer	1.11e-05	5.49e-05	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—prostate cancer	1.11e-05	5.47e-05	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—prostate cancer	1.1e-05	5.41e-05	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—prostate cancer	1.07e-05	5.26e-05	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—prostate cancer	1.06e-05	5.23e-05	CcSEcCtD
Quetiapine—Rash—Epirubicin—prostate cancer	1.06e-05	5.21e-05	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—prostate cancer	1.06e-05	5.21e-05	CcSEcCtD
Quetiapine—Headache—Epirubicin—prostate cancer	1.05e-05	5.18e-05	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—prostate cancer	1.03e-05	5.06e-05	CcSEcCtD
Quetiapine—Nausea—Epirubicin—prostate cancer	9.95e-06	4.91e-05	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—prostate cancer	9.86e-06	4.86e-05	CcSEcCtD
Quetiapine—Rash—Doxorubicin—prostate cancer	9.78e-06	4.82e-05	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—prostate cancer	9.77e-06	4.82e-05	CcSEcCtD
Quetiapine—Headache—Doxorubicin—prostate cancer	9.71e-06	4.79e-05	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—prostate cancer	9.21e-06	4.54e-05	CcSEcCtD
Quetiapine—HRH1—Signaling Pathways—PTEN—prostate cancer	9.46e-07	8.73e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—prostate cancer	9.45e-07	8.73e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—prostate cancer	9.45e-07	8.73e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	9.45e-07	8.72e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	9.45e-07	8.72e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—prostate cancer	9.45e-07	8.72e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	9.44e-07	8.71e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—prostate cancer	9.43e-07	8.7e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	9.42e-07	8.7e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	9.42e-07	8.7e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CREBBP—prostate cancer	9.41e-07	8.69e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—prostate cancer	9.4e-07	8.68e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—prostate cancer	9.4e-07	8.68e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	9.37e-07	8.65e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—prostate cancer	9.36e-07	8.64e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	9.34e-07	8.63e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	9.34e-07	8.62e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	9.33e-07	8.61e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—prostate cancer	9.31e-07	8.59e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	9.3e-07	8.59e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	9.28e-07	8.57e-06	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	9.26e-07	8.55e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—prostate cancer	9.26e-07	8.55e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—prostate cancer	9.25e-07	8.54e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	9.25e-07	8.54e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—prostate cancer	9.24e-07	8.53e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—prostate cancer	9.23e-07	8.52e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—prostate cancer	9.22e-07	8.52e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	9.2e-07	8.49e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—prostate cancer	9.19e-07	8.48e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—prostate cancer	9.19e-07	8.48e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	9.18e-07	8.47e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	9.17e-07	8.47e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—prostate cancer	9.16e-07	8.46e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—prostate cancer	9.16e-07	8.46e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—prostate cancer	9.14e-07	8.44e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	9.12e-07	8.42e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—prostate cancer	9.12e-07	8.42e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	9.1e-07	8.4e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	9.08e-07	8.38e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—prostate cancer	9.07e-07	8.38e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	9.05e-07	8.36e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	9.05e-07	8.35e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—prostate cancer	9.04e-07	8.35e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—prostate cancer	9.04e-07	8.35e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—prostate cancer	9.02e-07	8.33e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—prostate cancer	9.01e-07	8.32e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	9e-07	8.31e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—prostate cancer	9e-07	8.31e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—prostate cancer	8.99e-07	8.3e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—prostate cancer	8.96e-07	8.28e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—prostate cancer	8.96e-07	8.27e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—prostate cancer	8.94e-07	8.26e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—prostate cancer	8.94e-07	8.25e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	8.93e-07	8.25e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—prostate cancer	8.93e-07	8.25e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.92e-07	8.24e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—prostate cancer	8.92e-07	8.23e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	8.88e-07	8.2e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	8.88e-07	8.2e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—prostate cancer	8.88e-07	8.19e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—prostate cancer	8.87e-07	8.19e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—prostate cancer	8.85e-07	8.17e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—prostate cancer	8.85e-07	8.17e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	8.85e-07	8.17e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—prostate cancer	8.82e-07	8.15e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	8.8e-07	8.13e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—prostate cancer	8.79e-07	8.12e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LPL—prostate cancer	8.77e-07	8.1e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—prostate cancer	8.77e-07	8.1e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—prostate cancer	8.74e-07	8.07e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—prostate cancer	8.73e-07	8.06e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—prostate cancer	8.73e-07	8.06e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—prostate cancer	8.72e-07	8.05e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—prostate cancer	8.71e-07	8.04e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—prostate cancer	8.7e-07	8.03e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—prostate cancer	8.68e-07	8.02e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	8.67e-07	8.01e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	8.66e-07	8e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	8.64e-07	7.98e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—prostate cancer	8.63e-07	7.97e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—prostate cancer	8.63e-07	7.97e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	8.62e-07	7.96e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—prostate cancer	8.62e-07	7.95e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—prostate cancer	8.61e-07	7.95e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—prostate cancer	8.59e-07	7.93e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—prostate cancer	8.59e-07	7.93e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	8.56e-07	7.9e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—prostate cancer	8.54e-07	7.89e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—prostate cancer	8.54e-07	7.89e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—prostate cancer	8.53e-07	7.88e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	8.52e-07	7.86e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	8.49e-07	7.84e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	8.49e-07	7.84e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—prostate cancer	8.48e-07	7.83e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—prostate cancer	8.48e-07	7.83e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.47e-07	7.82e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—prostate cancer	8.46e-07	7.81e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—prostate cancer	8.46e-07	7.81e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—prostate cancer	8.43e-07	7.79e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—prostate cancer	8.43e-07	7.78e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—prostate cancer	8.42e-07	7.78e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	8.41e-07	7.77e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	8.41e-07	7.76e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—prostate cancer	8.4e-07	7.76e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—prostate cancer	8.4e-07	7.76e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	8.38e-07	7.74e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—prostate cancer	8.38e-07	7.74e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—prostate cancer	8.38e-07	7.74e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—prostate cancer	8.36e-07	7.72e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—prostate cancer	8.32e-07	7.68e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	8.3e-07	7.66e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—prostate cancer	8.3e-07	7.66e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—prostate cancer	8.25e-07	7.62e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—prostate cancer	8.22e-07	7.59e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—prostate cancer	8.18e-07	7.55e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—prostate cancer	8.17e-07	7.54e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—prostate cancer	8.15e-07	7.53e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—prostate cancer	8.06e-07	7.44e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	8.02e-07	7.41e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	8.02e-07	7.4e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—prostate cancer	8.01e-07	7.39e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—prostate cancer	8e-07	7.38e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—prostate cancer	7.99e-07	7.37e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—prostate cancer	7.97e-07	7.36e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—prostate cancer	7.93e-07	7.32e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—prostate cancer	7.9e-07	7.29e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—prostate cancer	7.88e-07	7.27e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—prostate cancer	7.86e-07	7.26e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—prostate cancer	7.86e-07	7.26e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—prostate cancer	7.86e-07	7.26e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	7.86e-07	7.26e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—prostate cancer	7.84e-07	7.24e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—prostate cancer	7.83e-07	7.23e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—prostate cancer	7.83e-07	7.23e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	7.82e-07	7.22e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—prostate cancer	7.81e-07	7.21e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	7.79e-07	7.19e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	7.79e-07	7.19e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.78e-07	7.18e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—prostate cancer	7.76e-07	7.16e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARA—prostate cancer	7.75e-07	7.15e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	7.74e-07	7.15e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—prostate cancer	7.73e-07	7.14e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—prostate cancer	7.72e-07	7.12e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	7.72e-07	7.12e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—prostate cancer	7.71e-07	7.12e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	7.71e-07	7.12e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—prostate cancer	7.71e-07	7.11e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—prostate cancer	7.7e-07	7.11e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	7.7e-07	7.11e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	7.69e-07	7.1e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—prostate cancer	7.69e-07	7.1e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—prostate cancer	7.66e-07	7.08e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—prostate cancer	7.64e-07	7.05e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—prostate cancer	7.56e-07	6.98e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	7.54e-07	6.97e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—prostate cancer	7.53e-07	6.96e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	7.49e-07	6.92e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—prostate cancer	7.49e-07	6.91e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—prostate cancer	7.45e-07	6.88e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—prostate cancer	7.4e-07	6.83e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	7.37e-07	6.81e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—prostate cancer	7.35e-07	6.79e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—prostate cancer	7.32e-07	6.76e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—prostate cancer	7.31e-07	6.75e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAV1—prostate cancer	7.28e-07	6.73e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—prostate cancer	7.28e-07	6.72e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—prostate cancer	7.28e-07	6.72e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—prostate cancer	7.26e-07	6.71e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—prostate cancer	7.26e-07	6.7e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—prostate cancer	7.26e-07	6.7e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—prostate cancer	7.25e-07	6.69e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—prostate cancer	7.24e-07	6.68e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—prostate cancer	7.22e-07	6.66e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—prostate cancer	7.17e-07	6.62e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	7.15e-07	6.6e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—prostate cancer	7.15e-07	6.6e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—prostate cancer	7.13e-07	6.58e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—prostate cancer	7.13e-07	6.58e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	7.13e-07	6.58e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—prostate cancer	7.1e-07	6.56e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	7.01e-07	6.47e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—prostate cancer	6.97e-07	6.43e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—prostate cancer	6.85e-07	6.33e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—prostate cancer	6.82e-07	6.3e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—prostate cancer	6.8e-07	6.28e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	6.8e-07	6.27e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—prostate cancer	6.72e-07	6.2e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	6.69e-07	6.17e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	6.67e-07	6.16e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—prostate cancer	6.67e-07	6.16e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	6.65e-07	6.14e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.64e-07	6.13e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—prostate cancer	6.63e-07	6.12e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	6.63e-07	6.12e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	6.62e-07	6.11e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—prostate cancer	6.57e-07	6.07e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	6.57e-07	6.06e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—prostate cancer	6.55e-07	6.05e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	6.55e-07	6.05e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—prostate cancer	6.53e-07	6.03e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—prostate cancer	6.48e-07	5.98e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—prostate cancer	6.47e-07	5.97e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—prostate cancer	6.45e-07	5.96e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—prostate cancer	6.43e-07	5.94e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—prostate cancer	6.41e-07	5.92e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—prostate cancer	6.41e-07	5.92e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—prostate cancer	6.35e-07	5.86e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—prostate cancer	6.33e-07	5.85e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—prostate cancer	6.32e-07	5.84e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—prostate cancer	6.29e-07	5.81e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—INS—prostate cancer	6.28e-07	5.8e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CREBBP—prostate cancer	6.15e-07	5.68e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—prostate cancer	6.12e-07	5.65e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	6.08e-07	5.62e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	6.02e-07	5.56e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—prostate cancer	6.02e-07	5.56e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—prostate cancer	5.94e-07	5.49e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—prostate cancer	5.92e-07	5.47e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—prostate cancer	5.91e-07	5.46e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—prostate cancer	5.89e-07	5.44e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—prostate cancer	5.89e-07	5.43e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—prostate cancer	5.87e-07	5.42e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.83e-07	5.39e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—prostate cancer	5.81e-07	5.37e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—prostate cancer	5.8e-07	5.35e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—prostate cancer	5.55e-07	5.13e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—prostate cancer	5.51e-07	5.09e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—prostate cancer	5.46e-07	5.04e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—prostate cancer	5.45e-07	5.03e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—prostate cancer	5.45e-07	5.03e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—prostate cancer	5.43e-07	5.02e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—prostate cancer	5.42e-07	5e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—prostate cancer	5.39e-07	4.97e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—prostate cancer	5.36e-07	4.95e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	5.35e-07	4.94e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.15e-07	4.76e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.08e-07	4.69e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.04e-07	4.65e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—prostate cancer	5.03e-07	4.65e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	4.97e-07	4.59e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.74e-07	4.38e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—prostate cancer	4.39e-07	4.06e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—prostate cancer	4.21e-07	3.89e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—prostate cancer	4.19e-07	3.87e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—prostate cancer	4.11e-07	3.79e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—prostate cancer	3.87e-07	3.58e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.1e-07	2.86e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—prostate cancer	2.53e-07	2.34e-06	CbGpPWpGaD
